Med. Pro Praxi 2009; 6(4): 191-194

Present possibilities for heart failure diagnosis in ambulatory care

MUDr. Jan Krupička, MUDr. Tomáš Janota CSc
III. interní klinika VFN a 1. LF UK, Praha

The number of heart failure (HF) patients is steadily increasing over the past several years, not only due to the population aging, but also

due to the improvement in therapy of cardiovascular diseases. With regard to long-term seriousness of HF therapy and adverse prognosis

of it’s advanced stages, new trends in cardiology put the accent on early and appropriate diagnosis especially in the ambulatory care.

The diagnosis of HF has remained fundamentally unchanged over the past several decades and has been based on the clinical history

and physical examination. The recent progress in laboratory and imaging technology facilitated and put forward the HF diagnosis. One

of these new methods was the assessment of natriuretic peptides, which are synthesized and secreted by myocardium in response to

increased cardiac wall stress during HF. Important progress was made also in the technology of echocardiographic devices. However, the

difficulties remain in the costingness of for instance natriuretic peptide assessment or in the availability and image quality of examinations

such as echocardiography. The aim of this article is to describe the practical value of different diagnostic methods.

Keywords: heart failure, diagnosis, natriuretic peptides, ambulatory care.

Published: September 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krupička J, Janota T. Present possibilities for heart failure diagnosis in ambulatory care. Med. praxi. 2009;6(4):191-194.
Download citation

References

  1. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003; 108: 977-982. Go to original source... Go to PubMed...
  2. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007; 93: 1137-1146. Go to original source... Go to PubMed...
  3. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NTproBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: The International Collaborative of NTproBNP Study. Eur Heart J 2006; 27: 330-337. Go to original source... Go to PubMed...
  4. McCullough PA, Nowak RM, McCord J, et al. B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure: Analysis From Breathing Not Properly (BNP) Multinational Study. Circulation 2002; 106: 416-422. Go to original source... Go to PubMed...
  5. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10: 933-989. Go to original source... Go to PubMed...
  6. Magga J, Marttila M, Mantymaa P, Vuolteenaho O, Ruskoaho H. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats. Endocrinology 1994; 134: 2505-2515. Go to original source... Go to PubMed...
  7. Maack T. The broad homeostatic role of natriuretic peptides. Arq Bras Endocrinol Metabol 2006; 50: 198-207. Go to original source... Go to PubMed...
  8. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure. N Engl J Med 2002; 347: 161-167. Go to original source... Go to PubMed...
  9. Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003; 107: 1278-1283. Go to original source... Go to PubMed...
  10. Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 2007; 49: 1733-1739. Go to original source... Go to PubMed...
  11. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Qui?ones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527-1533. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.